RyCarma

RyCarma is a clinical-stage biotech company developing first-in-class small molecule therapeutics for cardiovascular and skeletal muscle diseases

Biotech & Life Sciences

Sector

Seed

Stage

Biotech

Model

01Company Overview

RyCarma is a clinical-stage biotech company developing first-in-class small molecule therapeutics for cardiovascular and skeletal muscle diseases.

02Backed By1 investor

03Similar Companies

CP

Cardurion Pharmaceuticals

Biotech & Life Sciences

→

SB

C

AB

IB

04Startup DNA

8

signals

Sectors
Business Model
Technology